Where does National Cancer Center rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), National Cancer Center ranks #2,158 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does National Cancer Center hold?

National Cancer Center holds 183 US utility patents granted between 2015 and 2025, spanning 42 technology areas.

What is National Cancer Center's Innovation Score?

National Cancer Center has an Innovation Score of 53.8 out of 100 (top 8% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does National Cancer Center focus on?

National Cancer Center's top technology area is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties) with 76 patents, ranking #195 of 7,863 assignees active in that subclass. Grants appear in 42 CPC subclasses total.

Is National Cancer Center's patent grant rate increasing or decreasing?

National Cancer Center's recent grant velocity is +63% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for National Cancer Center's patents?

National Cancer Center's patents average 9.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the National Cancer Center patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

National Cancer Center

USPTO PatentsView assignee record - 183 granted patents across 42 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, National ranks #2,158 of 49,997 tracked US assignees by granted-patent volume, with 183 patents across 42 technology areas.

#2,158
of 49,997 US assignees by volume: Top 8%
by Innovation Score (53.8/100): 9.1
avg claims per patent: +63%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R2158 · Foreign Corporation #2,158 · 183 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-PAR · CLAIMS-PAR · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MID 183 grants
TOP-DECILE #2,158/49,997
PHOTO-FINISH Electro-Motive Diesel
CPC-WIDE G01N · 42 areas
INNOV-PAR 53.8/100
CLAIMS-PAR 9.1 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +63% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Electro-Motive Diesel, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How National’s 53.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 18.0 pts (33%) Velocity 7.4 pts (14%) Breadth 22.9 pts (43%) Claim depth 5.5 pts (10%)

Qualcomm Incorporated · highest

85
Desktop Metal · near

54
Federal-Mogul… · near

54
Leidos · near

54
National Cancer Center · this assignee

54
Xyleco · near

54
3D Lighting… · lowest

7

What this shows National's Innovation Score is 53.8/100 (top 8% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for National?

Each dot is one of National’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). National’s own 9.1 claims/patent is at or below the 17.6 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

National vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where National's grants concentrate

National Cancer Center is a focused PatentsView assignee: 42 CPC subclasses with 41.5% of grants classified under G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties). Peak complete grant year is 2020 (26 grants) versus a trough of 10 in 2016. By volume, National sits between Electro-Motive Diesel, Inc. and American Greetings Corporation.

National's three-year grant acceleration

From 2019–2021 to 2022–2024, National Cancer Center moved from 54 to 60 grants (1.11x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #938. See the growth leaderboard.

Electro-motive Di…

183
Huawei Cloud Comp…

183
Koninklijke Douwe…

183
Montres Breguet

183
Panasonic Healthc…

183
Pony AI

183
Wuhan Tianma Micr…

183
National Cancer C… ◀

183
American Greetings

182

What this shows National holds 183 patents at rank #2,158, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near National

By rank, the assignees closest to #2,158 in granted patent volume.

Leaders in G01N (Investigating OR Analysing Materials BY Determining Their…)

Other assignees with the most granted patents in National's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for National, neither rank-band nor same-CPC leaders (those blocks stay above). In G01N (Investigating OR Analysing Materials BY Determining Their…), National ranks #195 of 7,863 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (54 here).

Xyleco, Inc. 54 Federal-Mogul Powertrain LLC 54 Leidos, Inc. 54 Desktop Metal, Inc. 54

Similar claim depth

Nearest assignees by average claims per patent (9.1 here).

Assa Abloy Americas Residential Inc. 9.1 avg Institute of Geology and Geophysics, Chinese Academy of Sciences 9.1 avg Zumtobel Lighting GmbH 9.1 avg Dinkle Electric Machinery (CHINA) Co., Ltd. 9.1 avg

National's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

54 Top 8% higher than 92% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

National Cancer Center patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	12	6.6%
2016	10	5.5%
2017	14	7.7%
2018	13	7.1%
2019	13	7.1%
2020	26	14.2%
2021	15	8.2%
2022	22	12.0%
2023	14	7.7%
2024	24	13.1%
2025partial year	20	10.9%

Which technologies does National Cancer Center patent most?

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 76

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 67

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 63

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 57

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 55

C07K - Peptides 30

C12M - Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Fermenters 26

A61B - DIAGNOSIS; SURGERY; Identification 26

G06T - Image Data Processing OR Generation, IN General 16

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 9

C07D - Heterocyclic Compounds 8

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 7

G06F - Electric Digital Data Processing 6

G06V - Image OR Video Recognition OR Understanding 5

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 5

Top 15 of 42 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

National Cancer Center's patent record in context - here's where to go next.

National Cancer Center's lead technology class is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties), 41.5% of its portfolio - see every assignee active in that class. Explore G01N
Ranked #2,158 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare National Cancer Center against Electro-Motive Diesel, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 53.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.